Home > Quotes > SCLN

SciClone Pharmaceuticals, Inc. Quote & Summary Data

Get SCLN Alerts
*Delayed - data as of Apr. 28, 2016  -  Find a broker to begin trading SCLN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SCLN Pre-Market
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

SciClone Pharmaceuticals, Inc. Intraday Chart

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 13.33 $ 13.51
Low $ 12.94 $ 6.47

The current last sale of $13.19 is 103.86% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) is a United States ("US")-headquartered, China-focused, specialty pharmaceutical company with a substantial commercial business and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders. We are focused on continuing to grow our revenue and profitability. Our business and corporate strategy is focused primarily on the People's Republic of China ("China" or "PRC") where we have built a solid reputation and established a strong brand through many years of experience marketing our lead product, ZADAXIN (thymalfasin). In addition, we have an established product promotion business model with large pharmaceutical partners and we are focused on establishing profitability in all of these collaborations. We believe our sales and marketing strengths position us to benefit from the long-term expansion of the pharmaceutical market in China.  ... More ...  

Nasdaq Official Price

Research Brokers before you trade

Want to trade FX?